Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

YM BioSciences Inc.

http://www.ymbiosciences.com

Latest From YM BioSciences Inc.

Fracture Fixation Devices Market Projected A Return To Steady Growth

A new Informa Meddevicetracker report outlines projections for the fracture fixation devices market.

Market Intelligence Orthopedics

Market Intel: Expanding Applications And Improved Offerings To Drive Robotically Assisted Surgery Market

The global market for robotically assisted surgical devices will reach $11.5bn by 2025 as system improvements drive sales.

Market Intelligence Robotic Surgery

AbbVie U-Turns On Dong-A’s MerTK Program After Development Delays

After apparent long delays in development, AbbVie returns rights to Dong-A's MerTK program, with the South Korean pharma yet to determine the fate of the still preclinical stage assets.

South Korea Deals

Free Access To High-Cost Aducanumab May Incentivize Phase IV Trial Participants

Experts say there should be enough Alzheimer’s patients willing to enroll in Biogen/Eisai’s US FDA-required Phase IV trial and other companies’ late-stage studies even with Aduhelm broadly available. 

Clinical Trials Neurology
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Cytopia Limited
UsernamePublicRestriction

Register